La Merie

La Merie is a provider of information about biopharmaceutical R&D and competitive intelligence by Publishing, Consultancy and its Biotech Portal PipelineReview.com. La Merie produces, edits and publishes La Merie Daily, R&D Pipeline News, Competitor Analysis reports and full reports.

Results 1 - 20 of 79

previous 1 2 3 4 next

last

Title	Date	Price
FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART) Competitor Analysis	Nov 2009	£180
Thrombopoiesis-Stimulating Agents (TPO) Competitor Analysis	Nov 2009	£135
TGF-R Agonists and Antagonists Competitor Analysis	Nov 2009	£180
Competitor Analysis: Coagulation Factors	Oct 2009	£445
Competitor Analysis: EGF-R Agonists and Antagonists	Oct 2009	£270
Competitor Analysis: Her2 Receptor Antagonists	Sep 2009	£225
Competitor Analysis VEGF and VEGF-R Agonists and Antagonists	Sep 2009	£535
Coagulation Factors 2009 Target Pipeline and Corporate Benchmark Analysis	Aug 2009	£2,190
CHK and KSP/Eg5 Inhibitors Competitor Analysis	Aug 2009	£155
Competitor Analysis: Targeted Therapy of Hepatitis C	Aug 2009	£445
Immunotoxins Competitor Analysis	Jul 2009	£135
Bcr-Abl Kinase Inhibitors Competitor Analysis	Jul 2009	£180
PI3K-Akt-mTOR Pathway Inhibitors Competitor Analysis	Jul 2009	£445
IGF-1R Antagonists Competitor Analysis	Jul 2009	£225
HDAC Inhibitors Competitor Analysis	Jul 2009	£355
Immunocytokines Competitor Analysis	Jun 2009	£135
Antibody-Drug Conjugates (ADC) Competitor Analysis	Jun 2009	£225
Aurora Kinase Inhibitors Competitor Analysis	Jun 2009	£155
MEK Inhibitors Competitor Analysis	Jun 2009	£135
Raf Inhibitors Competitor Analysis	May 2009	£180